1.

Diagnosis (N) per month between March 2020 and March 2021.

2.

Diagnosis (N) per month between March 2020 and March 2021.

3.

Diagnosis (N) per month between March 2020 and March 2021.

1.

Number of episodes per city between March 2020 and March 2021.

2.

Number of episodes per city between March 2020 and March 2021.

3.

Number of episodes per city between March 2020 and March 2021.

1.

Baseline characteristics of study population and diagnosis groups.

2.

Baseline characteristics of study population and diagnosis groups.

3.

Baseline characteristics of study population and diagnosis groups.

1.

Symptoms per diagnosis group.

2.

Symptoms per diagnosis group.

3.

Symptoms per diagnosis group.

1.

Disease course per group between March 2020 and March 2021.

2.

Disease course per group between March 2020 and March 2021.

3.

Disease course per group between March 2020 and March 2021.

1.

Exposure to a Mixture of Endocrine-Disrupting Chemicals and Metabolic Outcomes in Belgian Adolescents

2.

Exposure to a Mixture of Endocrine-Disrupting Chemicals and Metabolic Outcomes in Belgian Adolescents

3.

Exposure to a Mixture of Endocrine-Disrupting Chemicals and Metabolic Outcomes in Belgian Adolescents

1.

Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis